Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study - Concepedia

Concepedia

Publication | Closed Access

Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

186

Citations

16

References

2012

Year

Hans‐Christoph Diener, Gilles Géraud, Miguel J. A. Láinez, Jean Schoenen, Nadja Harner, Alison Pilgrim, Uwe Reuter

The Lancet Neurology

Acute TreatmentCluster HeadacheMedicineNeuropharmacologyPharmacotherapyNeurologyDose-ranging StudyPhase 2Pharmacology

References

	Year	Citations

Page 1